M-1001

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameM-1001

Drug Alias NameM-1001MEDICA-M1001

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHepatocyte nuclear factor 4 modulatorsAMP-activated protein kinases modulatorsMitochondrial permeability transition pore modulators +[5]

TargetsSignal transducer and activator of transcription 3AMP-activated protein kinasesHepatocyte nuclear factor 4 +[5]

Therapy Area/IndicationsDyslipidemias

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSyndromex

China Registration ClassN/A

Develop Information

Active CompaniesSyndromex

Inactive CompaniesN/A

Active IndicationsDyslipidemias

Inactive IndicationsN/A

Other Information

ATC CodeN/A